IntelGenx secures licence to erectile dysfunction drug from Eli Lilly

22-11-2016

IntelGenx secures licence to erectile dysfunction drug from Eli Lilly

MJ Prototype / shutterstock.com

Canada-based oral drug company IntelGenx has secured a licence from Eli Lilly to a patent covering tadalafil.


IntelGenx, Eli Lilly, patent, tadalafil, Tadalafil VersaFilm, licence, erectile dysfunction

LSIPR